METHOD OF EXPERIMENTAL AMYLOIDOSIS MODELLING IN ANIMALS

FIELD: medicine. ^ SUBSTANCE: invention refers to experimental medicine and can be used for amyloidosis modelling in animals. It is enabled as follows. Native pig plasma is injected to golden hamsters every second day at 0.025 ml/g of body weight within 60 experimental days. Method provides adequate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOZYREV KONSTANTIN MURADIEVICH, PUKHOVA IRINA UMARBEKOVNA, BRIN VADIM BORISOVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: invention refers to experimental medicine and can be used for amyloidosis modelling in animals. It is enabled as follows. Native pig plasma is injected to golden hamsters every second day at 0.025 ml/g of body weight within 60 experimental days. Method provides adequate model reproduction that makes it possible to analyse pathogenesis, prevent and treat amyloidosis, specifically when researching functional kidneys health, blood circulation system, mineral metabolism and other indicators of experimental animals. ^ EFFECT: model reproduction that makes it possible to analyse pathogenesis, prevent and treat amyloidosis. ^ 1 ex, 5 dwg